Dilon Announces Positive Interim Results from EU MaginProbe® Study

[vc_row][vc_column][vc_column_text]Framingham, MA, July 09, 2010 – Dilon Devices, Inc. today announced that positive interim results from a European post-market study of the MarginProbe™ System, a technology to enable better detection and removal of cancerous tissue during breastconserving surgery (BCS), were presented at the German Breast Cancer Society Meeting (DGS 2010) held in Hamburg, Germany from…

Read More